Psoriasis and psoriasiform eruptions associated with propranolol--the role of an immunological mechanism.
Halevy
S
S
Department of Dermatology, Soroka Medical Center, Beer-Sheva, Israel.
Livni
E
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D001706:Biopsy; D002465:Cell Movement; D002648:Child; D004342:Drug Hypersensitivity / Q000276:immunology*; D006168:Guinea Pigs; D006801:Humans; D008214:Lymphocytes / Q000166:cytology / Q000276:immunology; D008263:Macrophage Migration-Inhibitory Factors; D008264:Macrophages / Q000166:cytology / Q000276:immunology; D008875:Middle Aged; D011433:Propranolol / Q000009:adverse effects*; D011565:Psoriasis / Q000139:chemically induced* / Q000276:immunology* / Q000473:pathology; D012867:Skin / Q000473:pathology
D008263:Macrophage Migration-Inhibitory Factors; D011433:Propranolol